Moderna said on Monday its combination vaccine to protect against both COVID-19 and influenza generated a stronger immune response in adults aged 50 and...
The US Food and Drug Administration approved Moderna's respiratory syncytial virus (RSV) vaccine, the company announced on Friday, giving it a shot at much-needed...
Moderna and Merck & Co said on Monday they have started a late-stage trial of their experimental personalized mRNA cancer treatment in combination with...
The US Food and Drug Administration (FDA) on Monday authorized updated COVID-19 vaccines from Pfizer/BioNTech and Moderna that target a recently circulating Omicron variant...
Moderna on Wednesday said clinical trial data showed its updated COVID-19 vaccine will likely be effective against the highly-mutated BA.2.86 subvariant of the coronavirus...
Moderna said on Thursday an initial study data showed its updated COVID-19 vaccine to be effective against the "Eris" and "Fornax" subvariants in humans.
The...
Moderna said on Wednesday its experimental personalised mRNA skin cancer vaccine in combination with Merck & Co's drug Keytruda has received breakthrough therapy designation...
Moderna has agreed to provide its new variant-adapted COVID-19 vaccine to the global scheme aiming to deliver shots to the world's poorest people.
The biotech...
Canada on Thursday authorized Moderna COVID-19 vaccine for babies as young as 6 months old, making it the country's first vaccine against coronavirus for...
Moderna said on Wednesday that an updated version of its COVID-19 vaccine designed to target the Omicron variant also generated a strong immune response...
The US Food and Drug Administration granted emergency authorization Friday for the use of Pfizer and Moderna Covid-19 vaccines in the youngest children, the...
WASHINGTON: Moderna's COVID-19 vaccine may have a higher risk of heart inflammation in young men than the Pfizer/BioNTech shot, according to data presented on...
UK's medicines regulator on Thursday approved the use of Moderna's (MRNA.O) COVID-19 vaccine in children between six and 11 years, as the country bolsters itself...
WASHINGTON: The US Food and Drug Administration (FDA) announced Monday that it has granted full approval to Moderna's Covid-19 "Spikevax" vaccine, which had previously...
Moderna said on Wednesday it had started a mid-stage study, testing a booster dose of its COVID-19 vaccine specifically designed to target the Omicron...